Potential utility of miRNAs for liquid biopsy in breast cancer.

Potential utility of miRNAs for liquid biopsy in breast cancer.
复制标题

DOI:
10.3389/fonc.2022.940314
复制
发表时间:
2022
影响因子:
4.7
通讯作者:
Ma, Jinfeng
Ma, Jinfeng
中科院分区:
医学3区
文献类型:
--
作者:
Liu, Xiangrong;Papukashvili, Dimitri;Wang, Zhixiang;Liu, Yan;Chen, Xiaoxia;Li, Jianrong;Li, Zhiyuan;Hu, Linjie;Li, Zheng;Rcheulishvili, Nino;Lu, Xiaoqing;Ma, Jinfeng

文献摘要

参考文献

相似文献

由于其在女性中的发病率、复发和转移,乳腺癌(BC)仍然是最常见的恶性肿瘤。癌症检测的传统策略——乳房X线照相术和组织活检缺乏检测完整癌症基因组图谱的能力。此外,它们经常给出假阳性或阴性结果。由于这一缺点以及其他缺点(例如侵入性、高成本和副作用)的存在,需要制定新的策略来克服 BC 负担。液体活检(LB)因其早期检测、筛查、预后、技术简单和高效监测而备受关注。值得注意的是,microRNA (miRNA)——基因表达调节因子似乎作为 LB 样本中检测到的生物标志物发挥着重要作用。特别是,miR-21 和 miR-155 以及其他可能的候选者似乎可以作为 BC 诊断和预后的有利生物标志物。因此,本综述将评估 miRNA 作为生物标志物的潜在效用,并将重点介绍 LB 方法在 BC 诊断和管理中的某些有前途的候选药物,这些候选药物可能会优化患者的治疗结果。
Breast cancer (BC) remains the most prevalent malignancy due to its incidence rate, recurrence, and metastasis in women. Conventional strategies of cancer detection– mammography and tissue biopsy lack the capacity to detect the complete cancer genomic landscape. Besides, they often give false- positive or negative results. The presence of this and other disadvantages such as invasiveness, high-cost, and side effects necessitates developing new strategies to overcome the BC burden. Liquid biopsy (LB) has been brought to the fore owing to its early detection, screening, prognosis, simplicity of the technique, and efficient monitoring. Remarkably, microRNAs (miRNAs)– gene expression regulators seem to play a major role as biomarkers detected in the samples of LB. Particularly, miR-21 and miR-155 among other possible candidates seem to serve as favorable biomarkers in the diagnosis and prognosis of BC. Hence, this review will assess the potential utility of miRNAs as biomarkers and will highlight certain promising candidates for the LB approach in the diagnosis and management of BC that may optimize the patient outcome.
DOI: 10.1016/j.esmoop.2020.100039
发表时间: 2021-03
期刊: ESMO open
影响因子: 7.3
作者:
Adam-Artigues A;Garrido-Cano I;Simón S;Ortega B;Moragón S;Lameirinhas A;Constâncio V;Salta S;Burgués O;Bermejo B;Henrique R;Lluch A;Jerónimo C;Eroles P;Cejalvo JM
通讯作者: Cejalvo JM
通过靶向VEGF和细胞周期蛋白D1基因,循环miRNA-373对乳腺癌诊断的影响。
DOI: 10.1186/s43141-021-00174-7
发表时间: 2021-06-05
期刊: Journal, genetic engineering & biotechnology
影响因子: --
作者:
Bakr NM;Mahmoud MS;Nabil R;Boushnak H;Swellam M
通讯作者: Swellam M
DOI: 10.1016/j.jare.2020.08.012
发表时间: 2021-03
影响因子: 10.7
作者:
Chakraborty C;Sharma AR;Sharma G;Lee SS
通讯作者: Lee SS
DOI: 10.3390/jcm9092920
发表时间: 2020-09-10
影响因子: 3.9
作者:
Chan HW;Yang B;Wong W;Blakeley P;Seah I;Tan QSW;Wang H;Bhargava M;Lin HA;Chai CH;Mangunkusumo EA;Thet N;Yuen YS;Sethi R;Wang S;Hunziker W;Lingam G;Su X
通讯作者: Su X
DOI: 10.1002/jso.22153
发表时间: 2012-09-01
影响因子: 2.5
作者:
Chen, Jian;Wang, Bing-Chan;Tang, Jin-Hai
通讯作者: Tang, Jin-Hai